1Hadeel Maan Rashied, 2Batool Mezher Naser, 3Hussein Khalid Zwain, 4Ali A. Al-fahham
1Medical Laboratory Techniques Department, College of Medical Technology, Islamic University of Najaf, Iraq
2College of Medical Technology, Islamic University of Najaf, Iraq
3Medical Laboratory Techniques Department, College of Medical Technology, Islamic University of Najaf, Iraq
4Faculty of Nursing, University of Kufa, Iraq
ABSTRACT:
Hypertension is the most important modifiable risk factor and, if treated, leads to a reduction in cardiovascular diseases and mortality. A recent perspective emphasizes the central role of nitric oxide bioavailability in the maintenance of healthy vasculature and the regulation of blood pressure. The molecule nitric oxide is very complex with far-reaching implications concerning cardiovascular well-being and pathology. Synthesis of nitric oxide as well as signaling cascades and their regulation thus stands as a critical process in acquiring an understanding regarding its involvement under physiological as well as pathological conditions. With the rapid pace at which NO research is evolving, there are significant gaps in our knowledge that must be filled in if we are ever to take full advantage of its therapeutic potential. Nitric oxide is also considered to be a very important molecule involved in the defense of hypertension through its effects on endothelial function and vascular homeostasis. This review will summarize the current state of knowledge regarding the relationship between NO and hypertension and will attempt to identify those areas where significant lacunae exist and where further research would be appropriate. In addition, focus is directed toward the structure and clinical relevance of NO, describing its functions in endothelial activity, cardiovascular health, and any possible clinical utility.
REFERENCES :
1) Andrukhova, O.., Slavic, S.., Zeitz, Ute., Riesen, S.., Heppelmann, M. S.., Ambrisko, T.., Markovic, Mato., Kuebler, W.., & Erben, R.. (2014). Vitamin D is a regulator of endothelial nitric oxide synthase and arterial stiffness in mice.. Molecular endocrinology , 28 1 , 53-64 . http://doi.org/10.1210/me.2013-1252
2) Bendall, J.., Douglas, G.., McNeill, E.., Channon, K.., & Crabtree, M.. (2014). Tetrahydrobiopterin in cardiovascular health and disease.. Antioxidants & redox signaling , 20 18 , 3040-77 . http://doi.org/10.1089/ars.2013.5566
3) Carnicer, R.., Crabtree, M.., Sivakumaran, V.., Casadei, B.., & Kass, D.. (2013). Nitric oxide synthases in heart failure.. Antioxidants & redox signaling , 18 9 , 1078-99 . http://doi.org/10.1089/ars.2012.4824
4) Cinelli, Maris A.., Do, H.., Miley, Galen P.., & Silverman, R.. (2020). Inducible nitric oxide synthase: Regulation, structure, and inhibition. Medicinal Research Reviews , 40 , 158 – 189 . http://doi.org/10.1002/med.21599
5) Farah, C.., Michel, L.., & Balligand, J.. (2018). Nitric oxide signalling in cardiovascular health and disease. Nature Reviews Cardiology , 15 , 292-316 . http://doi.org/10.1038/nrcardio.2017.224
6) Förstermann, U.., & Sessa, W.. (2012). Nitric oxide synthases: regulation and function.. European heart journal , 33 7 , 829-37, 837a-837d . http://doi.org/10.1093/eurheartj/ehr304
7) Galiè, N.., Channick, R.., Frantz, R.., Grünig, E.., Jing, Z.., Moiseeva, O.., Preston, I.., Pulido, T.., Safdar, Z.., Tamura, Yuichi., & McLaughlin, V.. (2019). Risk stratification and medical therapy of pulmonary arterial hypertension. The European Respiratory Journal , 53 . http://doi.org/10.1183/13993003.01889-2018
8) Gallo, G.., Volpe, M.., & Savoia, C.. (2022). Endothelial Dysfunction in Hypertension: Current Concepts and Clinical Implications. Frontiers in Medicine , 8 . http://doi.org/10.3389/fmed.2021.798958
9) Gambardella, J.., Khondkar, Wafiq., Morelli, M.., Wang, Xujun., Santulli, G.., & Trimarco, V.. (2020). Arginine and Endothelial Function. Biomedicines , 8 . http://doi.org/10.3390/biomedicines8080277
10) Hamblin, Michael R. (2018). Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation. Photochemistry and Photobiology , 94 . http://doi.org/10.1111/php.12864
11) Kuhn, V.., Diederich, L.., Keller, T. C.., Kramer, Christian M.., Lückstädt, Wiebke., Panknin, C.., Suvorava, T.., Isakson, B.., Kelm, M.., & Cortese-Krott, M.. (2017). Red Blood Cell Function and Dysfunction: Redox Regulation, Nitric Oxide Metabolism, Anemia. Antioxidants & Redox Signaling , 26 , 718 – 742 . http://doi.org/10.1089/ars.2016.6954
12) Li, Qiang., Youn, J.., & Cai, H.. (2015). Mechanisms and consequences of endothelial nitric oxide synthase dysfunction in hypertension.. Journal of hypertension , 33 6 , 1128-36 . http://doi.org/10.1097/HJH.0000000000000587
13) Lidder, S.., & Webb, A.. (2013). Vascular effects of dietary nitrate (as found in green leafy vegetables and beetroot) via the nitrate-nitrite-nitric oxide pathway.. British journal of clinical pharmacology, 75 3, 677-96.
http://doi.org/10.1111/j.1365-2125.2012.04420.x
14) Lundberg, J.., Gladwin, M.., & Weitzberg, E.. (2015). Strategies to increase nitric oxide signalling in cardiovascular disease. Nature Reviews Drug Discovery, 14 , 623-641 . http://doi.org/10.1038/nrd4623
15) Martínez-Ruíz, A.., Cadenas, S.., & Lamas, S. (2011). Nitric oxide signaling: classical, less classical, and nonclassical mechanisms. Free radical biology & medicine, 51 1 , 17-29 . http://doi.org/10.1016/j.freeradbiomed.2011.04.010
16) Nystoriak, Matthew A.., & Bhatnagar, A.. (2018). Cardiovascular Effects and Benefits of Exercise. Frontiers in Cardiovascular Medicine , 5 . http://doi.org/10.3389/fcvm.2018.00135
17) Oesterle, A.., Laufs, U.., & Liao, J.. (2017). Pleiotropic Effects of Statins on the Cardiovascular System. Circulation Research, 120 , 229–243 . http://doi.org/10.1161/CIRCRESAHA.116.308537
18) Tejero, J.., Shiva, S.., & Gladwin, M.. (2019). Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation. Physiological reviews , 99 1 , 311-379 . http://doi.org/10.1152/physrev.00036.2017
19) Tousoulis, D.., Kampoli, A.., Tentolouris, C.., Papageorgiou, N.., & Stefanadis, C.. (2012). The role of nitric oxide on endothelial function. Current vascular pharmacology, 10 1 , 4-18 . http://doi.org/10.2174/157016112798829760
20) Xia, N.., Daiber, A.., Förstermann, U.., & Li, Huige. (2017). Antioxidant effects of resveratrol in the cardiovascular system. British Journal of Pharmacology, 174, 1633 – 1646 . http://doi.org/10.1111/bph.13492